Poorly Differentiated Thyroid Gland Carcinoma

Poorly Differentiated Thyroid Gland Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

19 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 11
Recruiting: 3
Ph III recruiting: 0
Growth YoY: —
Industry share: 0%
Top sponsor: M.D. Anderson Cancer Center
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (2)

clinicaltrialsPublishedShowing 1–4 of 4 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02973997	Lenvatinib and Pembrolizumab in Differentiated Thyroid Cancers (DTC)	completed	Phase 2	57	Academic and Community Cancer Research UnitedOTHER	1	Aug 29, 2025	clinicaltrials
NCT02393690	Iodine I-131 With or Without Selumetinib in Treating Patients With Recurrent or Metastatic Thyroid Cancer	completed	Phase 2	60	Academic and Community Cancer Research UnitedOTHER	1	Jul 26, 2024	clinicaltrials